share_log

Ladenburg Thalmann Upgrades Evaxion Biotech to Buy, Announces $8 Price Target

Moomoo 24/7 ·  Apr 2 11:39

Ladenburg Thalmann analyst Ahu Demir upgrades Evaxion Biotech (NASDAQ:EVAX) from Neutral to Buy and announces $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment